Health Canada
- Status: approved
🇨🇦 Experimental: Rivaroxaban monotherapy in Canada
Experimental: Rivaroxaban monotherapy (Experimental: Rivaroxaban monotherapy) regulatory status in Canada.
Marketing authorisation
Experimental: Rivaroxaban monotherapy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Experimental: Rivaroxaban monotherapy approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Experimental: Rivaroxaban monotherapy in Canada?
Chinese Academy of Medical Sciences, Fuwai Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.